Literature DB >> 18452879

Computational analysis of the effects of the hERG channel opener NS1643 in a human ventricular cell model.

Torben Peitersen1, Morten Grunnet, Alan P Benson, Arun V Holden, Niels-Henrik Holstein-Rathlou, Søren-Peter Olesen.   

Abstract

BACKGROUND: Dysfunction or pharmacologic inhibition of repolarizing cardiac ionic currents can lead to fatal arrhythmias. The hERG potassium channel underlies the repolarizing current I(Kr), and mutations therein can produce both long and short QT syndromes (LQT2 and SQT1). We previously reported on the diphenylurea compound NS1643, which acts on hERG channels in two distinct ways: by increasing overall conductance and by shifting the inactivation curve in the depolarized direction.
OBJECTIVE: The purpose of this study was to determine which of the two components contributes more to the antiarrhythmic effects of NS1643 under normokalemic and hypokalemic conditions.
METHODS: The study consisted of mathematical simulation of action potentials in a human ventricular ionic cell model in single cell and string of 100 cells.
RESULTS: Regardless of external potassium concentration or diastolic interval used, NS1643 decreases action potential duration and triangulation. For single cells, NS1643 increases the postrepolarization refractory time but shortens the absolute refractory period. In one dimensional simulations, NS1643 increases the vulnerable window for unidirectional block but suppresses the emergence of premature action potentials and unidirectional blocks around APD(90). During normokalemia, shifting the inactivation curve has greater impact than increasing conductance, whereas the opposite occurs during hypokalemia.
CONCLUSION: Increased hERG conductance and the depolarizing shift of the inactivation curve both contribute to the antiarrhythmic actions of NS1643, with relative effects dependent on external K(+) concentration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452879     DOI: 10.1016/j.hrthm.2008.02.026

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  8 in total

1.  Models of HERG gating.

Authors:  Glenna C L Bett; Qinlian Zhou; Randall L Rasmusson
Journal:  Biophys J       Date:  2011-08-03       Impact factor: 4.033

Review 2.  Cardiac models in drug discovery and development: a review.

Authors:  Robert K Amanfu; Jeffrey J Saucerman
Journal:  Crit Rev Biomed Eng       Date:  2011

3.  Using computational modeling to predict arrhythmogenesis and antiarrhythmic therapy.

Authors:  Jonathan D Moreno; Colleen E Clancy
Journal:  Drug Discov Today Dis Models       Date:  2009

4.  Kinetic model for NS1643 drug activation of WT and L529I variants of Kv11.1 (hERG1) potassium channel.

Authors:  Laura L Perissinotti; Jiqing Guo; Pablo M De Biase; Colleen E Clancy; Henry J Duff; Sergei Y Noskov
Journal:  Biophys J       Date:  2015-03-24       Impact factor: 4.033

5.  Quantitative prediction of the arrhythmogenic effects of de novo hERG mutations in computational models of human ventricular tissues.

Authors:  Alan P Benson; Moza Al-Owais; Arun V Holden
Journal:  Eur Biophys J       Date:  2011-01-14       Impact factor: 1.733

6.  Deterministic and Stochastic Cellular Mechanisms Contributing to Carbon Monoxide Induced Ventricular Arrhythmias.

Authors:  Moza M Al-Owais; Derek S Steele; Arun V Holden; Alan P Benson
Journal:  Front Pharmacol       Date:  2021-04-28       Impact factor: 5.810

7.  Trigger vs. Substrate: Multi-Dimensional Modulation of QT-Prolongation Associated Arrhythmic Dynamics by a hERG Channel Activator.

Authors:  Michael A Colman; Erick A Perez Alday; Arun V Holden; Alan P Benson
Journal:  Front Physiol       Date:  2017-10-04       Impact factor: 4.566

Review 8.  Pharmacological activation of the hERG K+ channel for the management of the long QT syndrome: A review.

Authors:  Aziza El Harchi; Oriane Brincourt
Journal:  J Arrhythm       Date:  2022-06-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.